uniQure (QURE)
(Delayed Data from NSDQ)
$61.56 USD
-2.10 (-3.29%)
Updated Oct 10, 2025 03:59 PM ET
After-Market: $60.06 -1.50 (-2.43%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QURE 61.56 -2.10(-3.29%)
Will QURE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for QURE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QURE
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study
Strength Seen in uniQure (QURE): Can Its 247.7% Jump Turn into More Strength?
QURE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
3 Top Genomics Stocks to Add to Your Portfolio in 2025
Other News for QURE
Is QURE likely to continue higher? Slingshot Bullish shows up after sliding 3.29%
QURE makes New 52 Week Closing High on October 9
New 52 Week Closing High appears for QURE after 3.54% move
Making Money In Biotech Stocks
RBC Capital Sticks to Their Buy Rating for uniQure (QURE)